Cargando…

Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience

PURPOSE: Living-donor liver transplant emerged as an alternative treatment for end stage liver disease due to the lack of cadaveric organs availability that met the demand. In Portugal, pediatric living-donor liver transplant (P-LDLT) was initiated in 2001 in Portugal in order to compensate for the...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos, José Pedro Fernandes, Martins, Ricardo, Lopes, Maria Francelina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593358/
https://www.ncbi.nlm.nih.gov/pubmed/34796097
http://dx.doi.org/10.5223/pghn.2021.24.6.528
_version_ 1784599719975059456
author dos Santos, José Pedro Fernandes
Martins, Ricardo
Lopes, Maria Francelina
author_facet dos Santos, José Pedro Fernandes
Martins, Ricardo
Lopes, Maria Francelina
author_sort dos Santos, José Pedro Fernandes
collection PubMed
description PURPOSE: Living-donor liver transplant emerged as an alternative treatment for end stage liver disease due to the lack of cadaveric organs availability that met the demand. In Portugal, pediatric living-donor liver transplant (P-LDLT) was initiated in 2001 in Portugal in order to compensate for the scarcity of cadaveric organs for such cases. The aim of this study was to retrospectively analyze the morbi-mortality of the 28 donors included in P-LDLT program performed at Coimbra's Pediatric Hospital (CHUC), a Portuguese reference center. METHODS: We retrospectively collected pertinent donor data and stratified complications according to Clavien's scoring system. RESULTS: In total, 28.6% (n=8) of the donors had surgical complications. According to Clavien-Dindo's classification, two donors had major complications (Clavien grade ≥3), four donors had grade 2 complications, and two donors had grade 1 complications. There were no P-LDLT-related mortalities in the present case series. The most common verified complications were biliary tract injuries and superficial incisional infections, which are consistent with the complications reported in worldwide series. CONCLUSION: These patients from CHUC shows that donor hepatectomy in P-LDLT is a safe procedure, with low morbidity and without mortality.
format Online
Article
Text
id pubmed-8593358
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition
record_format MEDLINE/PubMed
spelling pubmed-85933582021-11-17 Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience dos Santos, José Pedro Fernandes Martins, Ricardo Lopes, Maria Francelina Pediatr Gastroenterol Hepatol Nutr Original Article PURPOSE: Living-donor liver transplant emerged as an alternative treatment for end stage liver disease due to the lack of cadaveric organs availability that met the demand. In Portugal, pediatric living-donor liver transplant (P-LDLT) was initiated in 2001 in Portugal in order to compensate for the scarcity of cadaveric organs for such cases. The aim of this study was to retrospectively analyze the morbi-mortality of the 28 donors included in P-LDLT program performed at Coimbra's Pediatric Hospital (CHUC), a Portuguese reference center. METHODS: We retrospectively collected pertinent donor data and stratified complications according to Clavien's scoring system. RESULTS: In total, 28.6% (n=8) of the donors had surgical complications. According to Clavien-Dindo's classification, two donors had major complications (Clavien grade ≥3), four donors had grade 2 complications, and two donors had grade 1 complications. There were no P-LDLT-related mortalities in the present case series. The most common verified complications were biliary tract injuries and superficial incisional infections, which are consistent with the complications reported in worldwide series. CONCLUSION: These patients from CHUC shows that donor hepatectomy in P-LDLT is a safe procedure, with low morbidity and without mortality. The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2021-11 2021-11-05 /pmc/articles/PMC8593358/ /pubmed/34796097 http://dx.doi.org/10.5223/pghn.2021.24.6.528 Text en Copyright © 2021 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
dos Santos, José Pedro Fernandes
Martins, Ricardo
Lopes, Maria Francelina
Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience
title Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience
title_full Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience
title_fullStr Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience
title_full_unstemmed Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience
title_short Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience
title_sort donor surgical morbidity in pediatric living-donor liver transplant: a portuguese experience
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593358/
https://www.ncbi.nlm.nih.gov/pubmed/34796097
http://dx.doi.org/10.5223/pghn.2021.24.6.528
work_keys_str_mv AT dossantosjosepedrofernandes donorsurgicalmorbidityinpediatriclivingdonorlivertransplantaportugueseexperience
AT martinsricardo donorsurgicalmorbidityinpediatriclivingdonorlivertransplantaportugueseexperience
AT lopesmariafrancelina donorsurgicalmorbidityinpediatriclivingdonorlivertransplantaportugueseexperience